Post by Grifols

Today, Grifols marked a key milestone with the groundbreaking of its new manufacturing facility in Lliçà de Vall (Barcelona). The event was attended by the President of the Government of Spain, Pedro Sánchez, along with other authorities, as well as Vice Chairman of the Grifols Board of Directors Raimon Grifols, and Board members Víctor Grifols Deu, Albert Grifols Coma-Cros and Tomás Dagá. With an initial investment of EUR 160 million, the new plant will increase Grifols’ plasma fractionation capacity by three million liters annually, helping meet the needs of more than 300,000 patients across Europe who rely on plasma-derived therapies.    This project goes beyond expanding capacity — it reinforces a long-term commitment to patients, innovation and sustainability by creating a 25-hectare biotechnology hub together with the Parets del Vallès complex, employing more than 3,700 people and including the creation of 400 new jobs.